11 completed, 5 recruiting, 4 terminated, 1 not yet recruiting. 6 Phase 1, 5 Not applicable, 5 Phase 3, 2 Early Phase 1, 1 Phase 2.
Follow Technetium: new trials by email Literature Review of Technetium trials Research Report on Technetium
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Superparamagnetic Iron Oxide for Sentinel Lymph Node Localization in Patients With Cutaneous Melanoma: MagMen-II Superparamagnetic Iron Oxide, Technetium (99mTc) - Melanoma (Skin Cancer) | Phase 3 | Not yet recruiting | Vastra Gotaland Region | 254 | 2026-10-01 | 2026-09-03 |
| Testing the Safety of the Anti-cancer Drug, Sn-117m-DTPA, for Advanced Cancers That Have Spread to Bones Biospecimen Collection, Bone Scan, Computed Tomography - Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma | Phase 1 | Withdrawn | National Cancer Institute (NCI) | 2026-10-01 | 2026-08-28 | |
| Sentinel Node Identification Using Gamma and Near-Infrared Imaging in TesticulAr MaLignancies Standard treatment: orchiectomy followed by drug therapy and, if necessary, retroperitoneal lymphadenectomy, sentinel lymph node mapping using technetium-99m (Tc-99m) and indocyanine green (ICG) with subsequent orchiectomy - Germ Cell Tumor of Testis | Recruiting | N.N. Petrov National Medical Research Center of Oncology | 60 | 2026-04-01 | 2026-08-27 | |
| Comparative Analysis of Biotinylated, Irradiated and 51-Chromium Radiolabeled Red Blood Cells for Analysis of Recovery and Survival After Autologous Transfusion Biotinylated Red Blood Cells (BioRBC), Irradiated Biotinylated Red Blood Cells (Irradiated BioRBC), 51 Chromium Labeled Red Blood Cells (51Cr RBC) - Healthy Volunteer Red Blood Cell Labeling Study; Not Disease Focused | Phase 1 | Recruiting | Jose Cancelas | 20 | 2026-04-01 | 2026-04-16 |
| Implementation of Indocyanine Green to Identify Sentinel Lymph Nodes During Surgery for Breast Cancer Technetium (99mTc), Indocyanine Green, Sentinel lymph node biopsy - Breast Cancer, Sentinel Lymph Node Biopsy (SLNB) | Not applicable | Recruiting | Isabelle Henskens | 1760 | 2025-04-18 | 2026-06-25 |
| A Phase II Clinical Study to Evaluate the Efficacy and Safety of Technetium [99mtc]-H7ND Injection in the Diagnosis of Peritoneal Metastasis of Gastrointestinal Malignant Tumor. Technetium [99mTc]-H7ND injection - Solid Tumor, Peritoneal Metastasis | Phase 2 | Recruiting | Jiaxing Pharmadax Genesis Pharmaceutical Technology Co.,Ltd. | 90 | 2025-03-12 | 2025-08-06 |
| Technetium [99mTc]-H7ND in Patients With Gastrointestinal Malignancies and Healthy Volunteers Technetium [99mTc]-H7ND injection - Solid Tumor | Phase 1 | Completed | Jiaxing Pharmadax Genesis Pharmaceutical Technology Co.,Ltd. | 24 | 2024-05-14 | 2025-07-15 |
| A Phase 1 Study of 99mTc-p5+14 in Healthy Volunteers and Patients With AL or ATTR Systemic Amyloidosis 99mTc-p5+14 is an amyloid reactive peptide labeled with technetium-99m., 99mTc-Pyrophosphate - Systemic Amyloidosis | Phase 1 | Recruiting | University of Tennessee Graduate School of Medicine | 31 | 2023-09-18 | 2026-07-24 |
| A French Observational Study of Indocyanine Green for Patients With Breast Cancer Having a Sentinel Lymph Node Biopsy. Sentinel lymph node identification, indocyanine green, methylene blue - Breast Cancer | Completed | BTG International Inc. | 101 | 2023-06-06 | 2024-05-10 | |
| 99mTc-3PRGD2 SPECT/CT for Integrin Imaging of Lung Cancer 99mTc-3PRGD2 injection - Lung Cancer, Lymph Node Metastasis | Phase 3 | Completed | RDO Pharm. | 409 | 2019-10-12 | 2024-07-01 |
| Radiation Dose in Humans From Orally Administered Tc99m-Heparin Computerized Tomography scan, Single Photon Emission Computed Tomography scans, Technetium Tc 99M - Eosinophilic Esophagitis | Early Phase 1 | Completed | University of Utah | 8 | 2016-07-01 | 2021-05-03 |
| Lymphoseek as Lymphoid Tissue Targeting Agent in Patients With Cancer of the Endometrium Lymphoseek plus Vital Blue Dye - Endometrial Cancer | Phase 1 | Terminated | University of California, San Diego | 2 | 2015-11-01 | 2018-10-15 |
| 99Tc-MDP in Postmenopausal Women With Differentiated Thyroid Cancer and Osteoporosis 99Tc-MDP, Fosamax - Differentiated Thyroid Cancer, Osteoporosis | Not applicable | Completed | Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | 142 | 2015-01-01 | 2021-11-17 |
| Study Assessing The Interest of Indocyanine Green Fluorescence Imaging With Radioisotope Method For Sentinel Lymph Node Biopsy in Patients With Breast Cancer indocyanine green, isotope - Breast Neoplasms | Phase 3 | Completed | Centre Hospitalier Universitaire de Saint Etienne | 99 | 2014-11-01 | 2018-04-09 |
| Determination of Left Ventricular Ejection Fraction Using Cardiac Angioscintigraphy stannous pyrophosphate, Technetium-99m, E-CAM Camera - Angioscintigraphy, Tomoscintigraphy | Not applicable | Unknown | Central Hospital, Nancy, France | 100 | 2014-01-01 | 2016-08-17 |
| Evaluation of the Effect of Fasting and Exercise on Uptake of Tc-99m Sestamibi in Breast Tissue Meal, Exercise, Sestamibi - Molecular Imaging | Phase 1 | Completed | Mayo Clinic | 154 | 2013-09-01 | 2017-04-18 |
| Compare Technegas Ventilation-Perfusion SPECT and Xenon Ventilation-Perfusion Planar Imaging for Pulmonary Embolism Technegas V SPECT imaging, Xenon-133 Ventilation Planar imaging - Pulmonary Embolism | Phase 3 | Terminated | Cyclomedica Australia PTY Limited | 18 | 2012-08-01 | 2015-11-10 |
| Opioid Induced Swallowing Difficulties and Risk for Pulmonary Aspiration Remifentanil, Placebo, Technetium - Opioid Induced Swallowing Disorders | Phase 4 | Completed | Region Örebro County | 25 | 2012-01-01 | 2012-08-22 |
| Half-Dose Radiopharmaceutical in Wide Beam Reconstruction Half-dose of the Tc99-m sestamibi (Cardiolite) - Myocardial Infarction, Ischemic Heart Disease | Not applicable | Terminated | Edwin Wu | 64 | 2011-10-01 | 2016-02-24 |
| Rubidium-82 - An Alternative Radiopharmaceutical for Myocardial Imaging(Rb-ARMI) Myocardial perfusion imaging using Rb-82 PET or Tc-99m or Tl SPECT - Coronary Artery Disease | Completed | Ottawa Heart Institute Research Corporation | 10000 | 2010-04-01 | 2019-11-21 |
Showing 20 of 23. Sign in to see all of them.
Breast Neoplasms (4) · Lung Neoplasms (3) · Coronary Artery Disease (2) · Lymphatic Metastasis (2) · Amyloidosis (1) · Carcinoma, Non-Small-Cell Lung (1) · Cardiomyopathies (1) · Cystic Fibrosis (1) · Deglutition Disorders (1) · Endometrial Neoplasms (1) · Eosinophilic Esophagitis (1) · Fasting (1) · Immunoglobulin Light-chain Amyloidosis (1) · Ischemia (1) · Melanoma (1)
Jiaxing Pharmadax Genesis Pharmaceutical Technology Co.,Ltd. (2) · Astellas Pharma Inc (1) · BTG International Inc. (1) · Billy W. Loo Jr. (1) · Central Hospital, Nancy, France (1) · Centre Hospitalier Universitaire de Saint Etienne (1) · Cyclomedica Australia PTY Limited (1) · Edwin Wu (1) · Isabelle Henskens (1) · Jose Cancelas (1) · Mayo Clinic (1) · N.N. Petrov National Medical Research Center of Oncology (1) · National Cancer Institute (NCI) (1) · Ottawa Heart Institute Research Corporation (1) · RDO Pharm. (1)
United States (10) · China (4) · France (3) · Canada (1) · Netherlands (1) · Russia (1) · Sweden (1)
Akash Sharma, MD (1) · Annemiek Doeksen, MD, PhD (1) · Billy Loo (1) · Chao Ma, MD (1) · David Leung, MD, PhD (1) · Edward M Aten, MD (1) · Edwin Wu, M.D., FACC (1) · Gerald Gleich, MD (1) · Jonathan S Wall, PhD (1) · Jose A Cancelas-Perez, MD, PhD (1) · Michael K O'Connor, PhD, R-D (1) · Michael McHale, MD, FACS (1)
PMID 19717485, PMID 21045179, PMID 21082298, PMID 25613340, PMID 27009167, PMID 29651739, PMID 30479286, PMID 42342397
2014 (1), R44CA143716 (1), UM1CA186712 (1)